Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Medullary 5 Thyroid Diseases 3 Thyroid Cancer, Papillary 3 Sarcoma 3 Lung Neoplasms 3 Central Nervous System Neoplasms 3 Wilms Tumor 2 Thoracic Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Neoplasms by Site 2 Neoplasms 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lung Diseases 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Head and Neck Neoplasms 2 Glioma 2 Ependymoma 2 Endocrine System Diseases 2 Endocrine Gland Neoplasms 2

Interventions

selpercatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia-Anorexia Syndrome × selpercatinib × 1 year × Clear all

NCT07146893 2026-01-15

FEATHER

University of Oklahoma

Phase EARLY_PHASE1 Not yet recruiting

Cachexia-Anorexia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡